tiprankstipranks
Gamida Cell Revises Executive Compensation Amid Financial Constraints
Company Announcements

Gamida Cell Revises Executive Compensation Amid Financial Constraints

Don't Miss our Black Friday Offers:

Gamida Cell Ltd (GMDA) has issued an update.

Gamida Cell Ltd. has revised the employment agreements with its executive officers, including the CEO, COO/CCO, General Counsel and Chief Compliance Officer, and Chief Medical and Scientific Officer, due to financial constraints. These executives agreed to reduce their severance payments and special bonuses linked to company performance or control changes. The new agreements specify terms for termination, notice periods, severance packages, and the treatment of equity awards in case of termination without cause or resignation for good reason. Additionally, special transaction bonus agreements have been terminated, and a retention bonus is introduced, subject to continuous employment through a set period.

Find detailed analytics on GMDA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTwo option delistings on April 9th
TheFlyXortx Therapeutics appoints Abigail Jenkins to board of directors
TipRanks Auto-Generated NewsdeskNavigating the Compliance Maze: Gamida Cell’s Approach to Data Privacy and Security Amid Global Regulations
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App